Summary: <p>Much of the way influential consulting firm McKinsey & Co. operates is shrouded in secrecy. But recent reporting by the <em>New York Times</em> has revealed some of the company’s secrets, including its involvement with <a href="https://www.nytimes.com/2019/02/01/business/purdue-pharma-mckinsey-oxycontin-opiods.html" target="_blank">controversial companies</a> like Purdue Pharma, the maker of OxyContin, as well as <a href="https://www.nytimes.com/2018/12/15/world/asia/mckinsey-china-russia.html" target="_blank">foreign leaders and governments</a> in Saudi Arabia and South Africa. Additional stories have focused on the firm’s <a href="https://www.nytimes.com/2019/02/19/business/mckinsey-hedge-fund.html" target="_blank">hedge fund MIO</a> and alleged <a href="https://www.nytimes.com/2019/02/19/business/mckinsey-bankruptcy-settlement.html" target="_blank">failures</a> to make required financial disclosures.</p> <p>McKinsey has defended its work around the world. In a <a href="https://www.nytimes.com/2018/12/15/world/asia/mckinsey-china-russia.html" target="_blank">statement</a>, the firm told the <em>Times</em> that “since 1926, McKinsey has sought to make a positive difference to the businesses and communities in which our people live and work.” </p> <p>This week on Money Talking, Charlie Herman talks with <em>New York Times </em>investigative editor Walt Bogdanich and investigative reporter Mike Forsythe about their reporting on the often hidden world of McKinsey and why it matters.</p>
